Flex Pharma Presenting At Two Upcoming Healthcare Investor Conferences In June 2015
BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (NASDAQ: FLKS):
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that it will present a corporate overview at the following upcoming healthcare investor conferences in June:
Help employers find you! Check out all the jobs and post your resume.
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that it will present a corporate overview at the following upcoming healthcare investor conferences in June:
Help employers find you! Check out all the jobs and post your resume.